GeneDx Holdings (WGS) Gains from Investment Securities (2020 - 2026)

GeneDx Holdings has disclosed Gains from Investment Securities across 7 years of filings, most recently posting $495000.0 for Q1 2026.

• In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $495000.0; the TTM figure through Mar 2026 stood at $2.9 million (up 31.64% YoY), while the FY2025 annual figure was $2.5 million, down 9.22% from the prior year.
• Gains from Investment Securities grew to $495000.0 in Q1 2026, from $131000.0 in the prior quarter.
• Over the last five years, Gains from Investment Securities for WGS reached as high as $57.6 million in Q4 2022 and fell as low as -$56.0 million in Q3 2022.
• The 5-year median for Gains from Investment Securities is $511500.0 (2024), against an average of $485500.0.
• Annual changes were most pronounced in 2024 — Gains from Investment Securities soared 1041.6% — and 2025, when it sank 304.73%.
• A 5-year view of Gains from Investment Securities shows it stood at $57.6 million in 2022, then tumbled by 105.73% to -$3.3 million in 2023, then slumped by 163.09% to -$8.7 million in 2024, then jumped by 101.51% to $131000.0 in 2025, then soared by 277.86% to $495000.0 in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $495000.0, $131000.0, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.